- Home
- EFSI vs CRBU Comparison
EFSI vs CRBU Comparison
Compare EFSI & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EFSI
- CRBU
- Stock Information
- Founded
- EFSI 1881
- CRBU 2011
- Country
- EFSI United States
- CRBU United States
- Employees
- EFSI N/A
- CRBU N/A
- Industry
- EFSI Major Banks
- CRBU Medicinal Chemicals and Botanical Products
- Sector
- EFSI Finance
- CRBU Health Care
- Exchange
- EFSI Nasdaq
- CRBU Nasdaq
- Market Cap
- EFSI 201.2M
- CRBU 165.8M
- IPO Year
- EFSI N/A
- CRBU 2021
- Fundamental
- Price
- EFSI $37.30
- CRBU $1.78
- Analyst Decision
- EFSI Strong Buy
- CRBU Strong Buy
- Analyst Count
- EFSI 2
- CRBU 3
- Target Price
- EFSI $39.50
- CRBU $6.67
- AVG Volume (30 Days)
- EFSI 8.9K
- CRBU 656.9K
- Earning Date
- EFSI 07-24-2025
- CRBU 11-05-2025
- Dividend Yield
- EFSI 3.37%
- CRBU N/A
- EPS Growth
- EFSI N/A
- CRBU N/A
- EPS
- EFSI 1.85
- CRBU N/A
- Revenue
- EFSI $61,734,000.00
- CRBU $9,121,000.00
- Revenue This Year
- EFSI N/A
- CRBU $9.23
- Revenue Next Year
- EFSI $28.84
- CRBU N/A
- P/E Ratio
- EFSI $19.82
- CRBU N/A
- Revenue Growth
- EFSI N/A
- CRBU N/A
- 52 Week Low
- EFSI $28.70
- CRBU $0.66
- 52 Week High
- EFSI $37.50
- CRBU $3.00
- Technical
- Relative Strength Index (RSI)
- EFSI 67.28
- CRBU 46.16
- Support Level
- EFSI $36.56
- CRBU $1.72
- Resistance Level
- EFSI $37.34
- CRBU $1.94
- Average True Range (ATR)
- EFSI 0.47
- CRBU 0.10
- MACD
- EFSI -0.11
- CRBU -0.01
- Stochastic Oscillator
- EFSI 74.14
- CRBU 26.53
About EFSI Eagle Financial Services Inc Common Stock
Eagle Financial Services Inc is a locally owned and managed financial institution. It offers retail and commercial banking services, including demand, savings and time deposits and consumer, mortgage, and commercial loans. It also offers telephone banking, internet banking, and mobile banking to its customers. The Company has three reportable operating segments, Community Banking, Marine Lending and Wealth Management. It generates a majority of its revenue from the Community Banking segment.
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.